Elekta
4775 Peachtree Industrial Boulevard
Building 300, Suite 300
Norcross
Georgia
30092
United States
Tel: 770-300-9725
Fax: 770-448-6338
Website: http://www.elekta.com/
Email: info.america@elekta.com
411 articles about Elekta
-
Mercurius Health equips Robert Janker Klinik with integrated oncology solutions from Philips and Elekta
5/10/2023
Royal Philips, a global leader in health technology, radiation therapy leader Elekta, and oncology service provider Mercurius Health announced the signing of a 3-year agreement under which Philips and Elekta will install state-of-the-art diagnostic and therapeutic oncology equipment and associated informatics solutions at Mercurius Health’s newly-acquired Robert Janker Klinik cancer center in Bonn, Germany.
-
Elekta: Interim report, May-January 2021/22
2/24/2022
The demand for Elekta's solutions continued to be strong in the third quarter, the fifth consecutive quarter with underlying order growth, resulting in Elekta's strongest order backlog ever.
-
Invitation to the presentation of Elekta's third quarter 2021/22
2/4/2022
Elekta invites analysts and investors to a presentation of the third quarter 2021/22 at 10:00 a.m. CET on February 24.
-
Elekta to appoint Tobias Hägglöv as Chief Financial Officer
1/7/2022
Elekta announced that it will appoint Tobias Hägglöv as Chief Financial Officer effective February 1, 2022, taking over from Johan Adebäck.
-
More cancer patients in Africa to benefit from advanced radiation therapy with Elekta Unity MR-Linac
11/25/2021
Elekta announced that its latest African order for Elekta Unity MR-Linac comes less than six months after the company introduced its ACCESS 2025 strategy, which includes giving more than 300 million people access to radiation therapy with the addition of 800 to 1,000 additional Elekta linacs in underserved markets.
-
Invitation to the presentation of Elekta's second quarter 2021/22
11/4/2021
Elekta invites analysts and investors to a presentation of the second quarter 2021/22 at 10:00 a.m. CET on November 25.
-
Award-winning abstracts confirm benefits of Elekta Unity in precision radiation therapy
10/29/2021
Elekta announced the presentation of new award-winning abstracts supporting the many benefits of Elekta Unity in treating cancer patients using precision radiation therapy.
-
Elekta establishes a framework for sustainability-linked bonds
10/29/2021
Elekta announced that it has established a Sustainability-Linked Bond Framework for issues of sustainability-linked bonds under its Medium Term Note Program.
-
Elekta Unity MR-Linac featured in 72 abstracts at European radiation oncology congress
8/31/2021
Elekta announced the presentation of 72 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac.
-
Elekta to address Indonesia's cancer care gap with direct presence
8/25/2021
Elekta announced that is has established permanent legal entity in Indonesia's capital, Jakarta in order to address the unmet need for high quality, modern cancer care.
-
Data from 14 leading cancer centers presented at AAPM highlight global adoption of Elekta Unity MR-Linac
7/23/2021
Elekta announced the presentation of 36 abstracts demonstrating the technical capabilities and clinical utility of the Elekta Unity MR-Linac.
-
Elekta radiotherapy system designed for changing cancer landscape now available for U.S. patients
6/17/2021
Elekta announced that its Elekta Harmony* radiation therapy system recently received U.S. FDA 510 clearance, paving the way for U.S. clinics to harness the system to treat a comprehensive range of indications using the latest radiotherapy techniques.
-
Elekta and Philips deepen strategic partnership in precise and individualized oncology care
6/7/2021
Elekta and Royal Philips signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
-
Elekta's new strategy to focus on growth and access to radiation therapy
6/7/2021
At Elekta's (EKTA-B.ST) Capital Markets Day, CEO, Gustaf Salford , and members from his executive management team introduced the company's mid-term strategy, called Access 2025. The strategy reflects the wor
-
Philips and Elekta deepen strategic partnership in precise and individualized oncology care
6/7/2021
Royal Philips, and Elekta signed agreements to deepen their existing strategic partnership to advance comprehensive and personalized cancer care through precision oncology solutions.
-
Elekta Nomination Committee's proposed Board of Directors for the 2021 Annual General Meeting
6/4/2021
The Nomination Committee of Elekta proposes that the 2021 Annual General Meeting re-elect Board members Laurent Leksell, who is also proposed to be re-elected as Chairman of the Board, Caroline Leksell Cooke, Johan Malmquist, Wolfgang Reim, Jan Secher, Birgitta Stymne Göransson and Cecilia Wikström.
-
100th Elekta Unity MR-Linac goes to St George's Hospital in New Zealand
6/1/2021
Elekta announces that St George's Hospital in Christchurch, New Zealand, has ordered an Elekta Unity MR-Linac, making it the 100th device sold since introduction.
-
Year-end report, May-April 2020/21
5/28/2021
During Elekta's fourth quarter, we drove strong order growth in all regions – both from market growth and market share gain – and we received our 100th Unity order.
-
Invitation to Elekta's Capital Markets Day 2021
5/20/2021
Elekta invites investors, analysts and financial media representatives to join Elekta's digital Capital Markets Day on June 7, 2021.
-
Invitation to the presentation of Elekta's fiscal year 2020/21
5/10/2021
Elekta invites analysts and investors to a presentation of the fiscal year 2020/21 at 10:00 a.m. CEST on May 28.